Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Pharmacy | 7 | 2025 | 58 | 3.380 |
Why?
|
| Papillomavirus Vaccines | 5 | 2025 | 174 | 2.740 |
Why?
|
| Papillomavirus Infections | 6 | 2025 | 376 | 2.540 |
Why?
|
| Education, Pharmacy | 5 | 2025 | 57 | 2.470 |
Why?
|
| Pharmacy | 2 | 2024 | 34 | 1.530 |
Why?
|
| Trust | 3 | 2025 | 167 | 1.130 |
Why?
|
| Curriculum | 5 | 2025 | 318 | 1.100 |
Why?
|
| Influenza Vaccines | 3 | 2021 | 58 | 0.950 |
Why?
|
| Intention | 2 | 2025 | 108 | 0.910 |
Why?
|
| Multilingualism | 1 | 2025 | 52 | 0.890 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2025 | 989 | 0.880 |
Why?
|
| Mexican Americans | 1 | 2025 | 226 | 0.750 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2024 | 226 | 0.720 |
Why?
|
| Parents | 1 | 2025 | 370 | 0.680 |
Why?
|
| Vaccines | 1 | 2021 | 65 | 0.660 |
Why?
|
| Mexico | 6 | 2025 | 298 | 0.660 |
Why?
|
| Alphapapillomavirus | 1 | 2020 | 31 | 0.640 |
Why?
|
| Health Occupations | 1 | 2020 | 19 | 0.620 |
Why?
|
| Refugees | 1 | 2020 | 21 | 0.620 |
Why?
|
| Inflammation | 1 | 2025 | 758 | 0.610 |
Why?
|
| Humans | 25 | 2025 | 43102 | 0.560 |
Why?
|
| Pilot Projects | 3 | 2025 | 760 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 760 | 0.510 |
Why?
|
| Texas | 5 | 2025 | 457 | 0.470 |
Why?
|
| Neoplasms | 2 | 2023 | 1377 | 0.460 |
Why?
|
| Male | 13 | 2025 | 23409 | 0.430 |
Why?
|
| Adult | 8 | 2025 | 13872 | 0.420 |
Why?
|
| Female | 12 | 2025 | 24698 | 0.410 |
Why?
|
| Middle Aged | 5 | 2025 | 12222 | 0.360 |
Why?
|
| Educational Measurement | 2 | 2024 | 102 | 0.360 |
Why?
|
| Interprofessional Relations | 2 | 2023 | 59 | 0.340 |
Why?
|
| Vaccination | 4 | 2021 | 355 | 0.340 |
Why?
|
| United States | 6 | 2025 | 5205 | 0.320 |
Why?
|
| HIV Infections | 1 | 2024 | 2586 | 0.300 |
Why?
|
| Influenza, Human | 2 | 2019 | 92 | 0.270 |
Why?
|
| Mental Health | 2 | 2021 | 385 | 0.250 |
Why?
|
| Aged | 3 | 2025 | 8214 | 0.250 |
Why?
|
| Acculturation | 2 | 2018 | 205 | 0.240 |
Why?
|
| Hair | 1 | 2025 | 38 | 0.230 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3156 | 0.230 |
Why?
|
| Child | 2 | 2025 | 3443 | 0.220 |
Why?
|
| Self Efficacy | 1 | 2025 | 215 | 0.210 |
Why?
|
| Adolescent | 3 | 2025 | 6081 | 0.210 |
Why?
|
| Universities | 2 | 2025 | 559 | 0.200 |
Why?
|
| Students | 3 | 2024 | 626 | 0.190 |
Why?
|
| Focus Groups | 1 | 2025 | 423 | 0.190 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 231 | 0.190 |
Why?
|
| Inpatients | 1 | 2023 | 78 | 0.190 |
Why?
|
| Faculty | 2 | 2020 | 105 | 0.190 |
Why?
|
| Young Adult | 3 | 2023 | 5080 | 0.180 |
Why?
|
| Health Personnel | 1 | 2025 | 277 | 0.180 |
Why?
|
| Medically Underserved Area | 1 | 2023 | 120 | 0.180 |
Why?
|
| Telemedicine | 1 | 2025 | 234 | 0.180 |
Why?
|
| Choice Behavior | 1 | 2022 | 93 | 0.170 |
Why?
|
| Cohort Studies | 2 | 2023 | 1759 | 0.170 |
Why?
|
| Receptors, Nicotinic | 1 | 2022 | 114 | 0.170 |
Why?
|
| Body Mass Index | 1 | 2025 | 925 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2020 | 497 | 0.170 |
Why?
|
| Prefrontal Cortex | 1 | 2022 | 164 | 0.160 |
Why?
|
| Education, Graduate | 1 | 2020 | 31 | 0.160 |
Why?
|
| Quality of Life | 2 | 2022 | 616 | 0.150 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 91 | 0.150 |
Why?
|
| Language | 1 | 2021 | 185 | 0.150 |
Why?
|
| Nicotine | 1 | 2022 | 302 | 0.140 |
Why?
|
| Risk Factors | 1 | 2025 | 3994 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 1070 | 0.120 |
Why?
|
| Health Status | 1 | 2020 | 442 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 830 | 0.110 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 609 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2019 | 1600 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2024 | 156 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 375 | 0.050 |
Why?
|
| Anxiety | 2 | 2021 | 874 | 0.050 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2022 | 46 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2022 | 83 | 0.040 |
Why?
|
| Nicotinic Agonists | 1 | 2022 | 88 | 0.040 |
Why?
|
| Videotape Recording | 1 | 2020 | 29 | 0.040 |
Why?
|
| Schools, Pharmacy | 1 | 2020 | 19 | 0.040 |
Why?
|
| Caregivers | 1 | 2022 | 197 | 0.040 |
Why?
|
| Professional Competence | 1 | 2019 | 42 | 0.040 |
Why?
|
| Disclosure | 1 | 2019 | 39 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 215 | 0.040 |
Why?
|
| Crime Victims | 1 | 2018 | 77 | 0.030 |
Why?
|
| Latin America | 1 | 2017 | 55 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2022 | 1766 | 0.030 |
Why?
|
| Motivation | 1 | 2020 | 513 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1081 | 0.030 |
Why?
|
| Depression | 1 | 2021 | 863 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3735 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2019 | 638 | 0.030 |
Why?
|
| Animals | 1 | 2022 | 16992 | 0.010 |
Why?
|